• Save
Perak biotechnology business plan
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
1,449
On Slideshare
1,449
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. PERAK BIOTECHNOLOGY BUSINESSPLAN WTI Consulting, 9.12.2010
  • 2. PERAK BIO KPI
  • 3. PERAK BIO - TRANSFORMATION Having more professional, technical and support staff. Creating of relevant departments with particular expertise Working towards financial independence.
  • 4. REVISED MANAGEMENTSTRUCTURE
  • 5. CAPITAL RAISING PROGRAMMES
  • 6. EXISTING ASSETS AND GAPS
  • 7. PERAK BIOTECH PROJECT FUNDINGSTRUCTURE Listing PKNP Funder – (PBTP-160ac Cash Special Purpose + SIPP -60 Vehicle ac) Technology Invest IP Industry Centres of Excellence •Animal Vaccine •Bioinformatics •Wing-M Chemical •Biozyme Pharmatech •Global Tropical Life •Medical Device Sciences Institute •Boar Goat Artificial •Incubators Insemination Breeding •Advisory Centre scheme •Perak Biotech Park •Cattle Artificial Breeding scheme •Standards and Biosecurity
  • 8. POTENTIAL INVESTORS: Inventages Venture Capital, Life Sciences Venture Capital, London, interested to invest in selected Malaysian biotechnology projects; A group of private equity partners from South Africa, the United States, China, Canada, India and Indonesia. They will be making visits to Perak commencing in the first week of December 2010. A group of private equity through Goldman Sachs and UBS who are willing to consider investments from April 2011 onwards. Support from Malaysian Biotech Corp and PEMANDU
  • 9. TOWARDS FINANCIALINDEPENDENCE
  • 10. INVESTMENT BASED Global Tropical Life Sciences Institute and its subsidiaries; Bioinformatics Services; Development and Management of Perak Biotechnology Park; Investment in potential joint venture partners in various biotechnology sectors. Investment approach:  Ordinary shares in certain companies as strategic investment and strategic partners;  Preference Shares in certain companies as strategic investment and with a view of guaranteed income;  Loan stock and debentures with strategic exit and guaranteed income.
  • 11. ROYALTY BASED Licensing of intellectual property under the CBioD Initiatives. Royalty rate may vary from one sector to another but may range from 5% to 15% of the total gross sale.
  • 12. SALIENT TERMSCollaboration 1. Share of IP ownership at 51% to PerakAgreement between Bio and 49% to PEO.Perak Bio and PEO. 2. Share of Royalty at 51%: 49% after cost. 3. PEO to handle all digitisation of FRIM and non FRIM images of biodiversity 4. PEO to store and manage the data at the PEO data centre. 5. Perak Bio to manage the intellectual properties 6. Perak Bio be responsible to FRIM, access to taxa and also access to Temenggor and Belum for future non- FRIM projects. 7. Management committee to manage the collaboration 8. IP 50:50 ownership : ultimately 25:25:50 9. Marketing, development of enhanced IP, IP management of the enhance d IP
  • 13. INTELLECTUAL PROPERTIES ANDROYALTY Trademark – CpBioD Logo and Brand Copyright – Digitised format of CpBioD species Patents (?) – Methods of digitisation? Royalty Rates (as in various markets): 3-15%  Software (media content): 20-25%  Long term real property (CBioD City, Hotel) : 3%  Merchandising : 3-10% depending on product range  Tourism (long term): 3%  Travel and tours: events 5-15%
  • 14. JUSTIFICATION ON MARKET BASEDROYALTY RATESScope Rate on % of Justification gross profitSoftware – media 20-25% Average industry rate is 25% - 40%content as it has fast product cycle with higher industry average profit marginReal Property – 7-10% The use of copyrights and trademarksHotels etc reflect the long term business with low profit margin hence lower royalty rateMerchandising 7-15% The lower end reflects the same justification as above but the higher end of the rate may be charged on high end productsTourism 7-10% Same as aboveEvent 10-15% Same as above
  • 15. SALES REVENUE Developing and managing Perak Biotech Park. Biotechnology Advisory Centre (cooperate with KPerak); As the manager and approving authority for bioprospecting and access to genetic resources in the 9000 hectares Temenggor forest under the PITC; Standards Certification agency for biotechnology products and biodiversity management in Malaysia and other countries:  compliance with National Biodiversity Policy,  Certification process recognised by FSC and ISO,  Protocol for Research Based Tourism and Research and  Bioprospecting in the mega biodiversity areas.
  • 16. BIOTECHNOLOGY ADVISORYCENTRE Web based – contents and Transfer of email the experts Foreign knowledge to local and local understudies experts and advisors National Advisory Centre for Biotechnology Regulations and Commercialisation Manager Physical Office and staff Various clients Capacity Building
  • 17. PERAK BIOTECHNOLOGY PARK
  • 18. OBJECTIVES Enterprise development Job and skill creation Investment Attraction Export and trade Innovation and entrepreneurship Diversification of Perak Economy Sustainable economy
  • 19. PERAK BIOTECHNOLOGY PARK:DEVELOPMENT STRUCTURE Perak Strategic Partner: Federal Hitech Sale and Perak Contract Project Management, Government Park Sdn Purchase Bio Project Implementation, Bhd Marketing, Promotion Financial Main Support Project Design infra Owner Build Manageme nt Promotion Marketing Support system Perak Biotechnology Park
  • 20. REQUEST FOR APPROVAL Perak Bio Board to appoint a team lead by Amal Architech, Kuala Lumpur to:  Plan the development of the Perak Biotechnology Park  Plan the development of Global Tropical Life Sciences Institute, Incubators and other facilities on Perak Biotechnology Park;  To be the Project Manager;  To market Perak Biotechnology Park
  • 21. PROPOSED TRANSACTIONAL METHOD Perak Bio enters into S&P with Perak Hitech Park:  Deferred payment basis – PHTP will be paid based on the progress of each industrial lot.  PHTP will be paid an RM x amount, and will build the basic infrastructure.  PHTP to pay premium to the state. Perak Bio and Project and Marketing Managers  Perak Bio will appoint Project and Marketing Managers on success basis;  Perak Bio will be paid RM Y amount from the progress sale  Project Manager to obtain professional fees and profits from the sale of each lots  Project Manager to look for funding of the rest of development of Perak Biotech Park
  • 22. STAGES OF DEVELOPMENT
  • 23. MILESTONESDevelop the Plan for the Optimum Park for Perak 2H10including Designing the Park including the service of therelevant expertsMarketing of the Park: Aggressively promote and recruit 2010-2012new investments from leading biotechnology andpharmaceutical companies to fully populate the PerakBiotechnology ParkInitiate Links with All Stakeholders in the Perak 2010/11Biotechnology Park (Universities, Companies, EmployeeBase)Transaction with the First Company to Locate at the Perak 2H10Biotechnology Park
  • 24. PERAK BIOTECH PARK - CONCEPT Utilise renewable energy and sustainable energy building concept Limit on use of motor vehicle, encourage use of bicycles, battery powered cars, walking Industrial Lots for manufacturing and production meeting highest standards Perak Bio HQ, PLSI, Centres of Excellence Recreational facilities
  • 25. PREFERRED CLUSTERS IN THE PERAKBIOTECH PARK
  • 26. PREFERRED CLUSTERS IN THE PERAK BIOTECHPARK: R&D
  • 27. PERAK BIOINFORMATICS ANDTRADITIONAL KNOWLEDGEDIGITAL LIBRARYPROJECT
  • 28. OBJECTIVES
  • 29. STRUCTURE
  • 30. IMPLEMENTATION (1) Protection Link
  • 31. IMPLEMENTATION (2)Biodiversit Perak Global Data Fee y and TK Bioinformati Users Fund cs Customers R&D Institute Access Pharma Companies Access Royalt y Research and Development Perak Life Sciences Institute Commercialisati Perak Biotechnology Incubators on
  • 32. GLOBAL TROPICAL LIFE SCIENCES INSTITUTE32
  • 33. VALUE PROPOSITION 33
  • 34. FORMATION 34
  • 35. POTENTIAL PARTNERS 35
  • 36. MISSION AND OBJECTIVES 36
  • 37. POTENTIAL INVESTMENT/ EXPANSION TOPERAK (1)No Company Country of Field Estimated Origin Potential Value (RM)1 Wing-M Chemical Malaysia Biomass, 30,000,000 diesel substitute2 Wing-M Chemical JV Malaysia / Bamboo 50,000,000 with Xiamen Investor China based textile material3 Biozyme Pharmatech Taiwan Glucosamine 50,000,000 from vegetable (healthcare)4 Hirugen Biopharma Malaysia / Pharmaceuti 50,000,000 China cal (Clinical Clinical Trial Trial) Contract Research 150,000,000 (production)
  • 38. POTENTIAL INVESTMENT/ EXPANSION TO PERAK (2)No Company Country of Field Estimated Origin Potential Value (RM)5 Jeffi Malaysia/ Aquaculture 200,000,000 China6 1st Global Biotech Malaysia / Healthcare 20,000,000 Taiwan Enzyme7 Pharco Medical Device Egypt / Medical 50,000,000 Australia Device8 Medical Devices Malaysia/ Medical 50,000,000 Germany Device
  • 39. POTENTIAL INVESTMENT/ EXPANSION TO PERAK (3)No Company Country of Field Estimated Origin Potential Value (RM)9 Global Tropical Life Malaysia/ Research and 400,000,000 Sciences Institute International Development Centre of Excellence10 AIAZ JV Malaysia Animal 300,000,000 Vaccine11 Bioinformatics Malaysia Bioinformatics 20,000,00012 Animal Biotechnology Malaysia Animal 60,000,000 (3 companies) biotechnology
  • 40. POTENTIAL PERAK BIO REVENUEPerakBio Corporation Sdn BhdConsolidated Income For 5 Years Period Year1-2011 Year2-2012 Year3-2013 Year4-2014 Year5-2015Net Income ReceivableLife Science Institue - 600,000.00 600,000.00 750,000.00 750,000.00Royalty Fees - 340,000.00 848,000.00 1,356,000.00 2,032,000.00BioInformatic - 600,000.00 600,000.00 750,000.00 750,000.00Rental Income-Hitech&Iskandar - - 3,293,136.00 3,457,792.80 3,630,682.44Preference Shares Participation 600,000.00 2,400,000.00 2,400,000.00 2,400,000.00 2,400,000.00Incubator - - 3,000,000.00 3,000,000.00 3,750,000.00Product & Services 213,500.00 311,500.00 357,000.00 420,000.00 437,500.00Total Income 813,500.00 4,251,500.00 11,098,136.00 12,133,792.80 13,750,182.44
  • 41. ESTIMATED ECONOMIC IMPACT ON PERAK’S ECONOMY1 Total estimated Investment 1.06 Billion2 Estimated Annual Sale 400 million3 Estimated Annual Salary 20 million Creation of Support Industries: Housing, Bookstores,4 Food Supply, Specialised Transportation, IP and Legal Services, specialised accounting, computing, data Centres, Hotels, Conference Centres, housing, international School. Annual Economic turnover 100,000,000
  • 42. REQUEST Right to implement projects planned/ referred to WTI Consulting, in consultation with Perak Bio and KE PKNPk. Right to work with various PKNPk subsidiaries and to co ordinate with various government departments Easier access to land including state lands To organise trade mission/ marketing trips and to bring along representative from Perak Bio Management and Board members in order to convince investors (funding to be arranged separately)